Skip to main content
. 2020 Mar 12;16:1744806920911543. doi: 10.1177/1744806920911543

Figure 5.

Figure 5.

Knockdown of GluA1 in central amygdala potentiates morphine withdrawal-induced aversion. CPA behavior in rats with naloxone-precipitated morphine withdrawal (a, n = 8 rats each group) and in rats conditioned with saline and naloxone (b, n = 6 rats each group) after bilateral infusion of AAV-GluA1-shRNA or AAV-GluA1-scrambled (scr) shRNA into CeA. **p <0.01. ****p <0.0001 (two-way analysis of variance).